Treatment with Trichostatin A can activate caspase-9 and release mitochondrial cytochrome c and diablo, IAP-binding mitochondrial protein (DIABLO; Smac) in TRAIL resistant prostate cancer cells[122]. Here, DIABLO is linked to prostate carcinoma.